RSLS - ReShape Lifesciences reports FY results April, 25 2023 04:54 PM ReShape Lifesciences Inc. 2023-04-25 16:54:28 ET ReShape Lifesciences press release ( NASDAQ: RSLS ): FY Revenue of $11.24M (-17.9% Y/Y) misses by $2.24M . Net loss of $46.21M For further details see: ReShape Lifesciences reports FY results